We are expanding our product portfolio by offering assays and services for the Modaplex, a novel molecular diagnostic platform that bridges the gap between qPCR and Next Generation Sequencing.

Its unique combination of PCR amplification and parallel performed capillary electrophoresis enables the quantification of up to 50 DNA and/or RNA markers per sample within 3.5 hours. Explore all the additional advantages it creates for your molecular diagnostics, either for customized development, routine use, or for technology transfer.

Learn more

March 28-31, 2022, Virtual

We launch 3 new assays on our molecular diagnostic platform ModaplexTM:

  • Modaplex KRAS Mutation Analysis Kit
  • Modaplex NRAS Mutation Analysis Kit
  • Modaplex BRAF Mutation Analysis Kit

The kits (research use only) enable the detection of 13 KRAS, 13 NRAS, and 4 BRAF (KNB) mutations together in a single run.

Learn more

Biotechnology and medical technology companies based in Saxony made a significant contribution to combating the corona pandemic.

Learn more